NO20005372D0 - FremgangsmÕter og sammensetninger for Õ stabilisere acetylcholinsammensetninger - Google Patents

FremgangsmÕter og sammensetninger for Õ stabilisere acetylcholinsammensetninger

Info

Publication number
NO20005372D0
NO20005372D0 NO20005372A NO20005372A NO20005372D0 NO 20005372 D0 NO20005372 D0 NO 20005372D0 NO 20005372 A NO20005372 A NO 20005372A NO 20005372 A NO20005372 A NO 20005372A NO 20005372 D0 NO20005372 D0 NO 20005372D0
Authority
NO
Norway
Prior art keywords
acetylcholine
compositions
buffered
stabilize
product
Prior art date
Application number
NO20005372A
Other languages
English (en)
Other versions
NO20005372L (no
Inventor
Fu-Pao Tsao
George Edward Minno
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20005372L publication Critical patent/NO20005372L/no
Publication of NO20005372D0 publication Critical patent/NO20005372D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymerisation Methods In General (AREA)
NO20005372A 1998-04-29 2000-10-25 FremgangsmÕter og sammensetninger for Õ stabilisere acetylcholinsammensetninger NO20005372D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6955298A 1998-04-29 1998-04-29
PCT/EP1999/002846 WO1999055304A1 (en) 1998-04-29 1999-04-27 Methods and compositions for stabilizing acetylcholine compositions

Publications (2)

Publication Number Publication Date
NO20005372L NO20005372L (no) 2000-10-25
NO20005372D0 true NO20005372D0 (no) 2000-10-25

Family

ID=22089751

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005372A NO20005372D0 (no) 1998-04-29 2000-10-25 FremgangsmÕter og sammensetninger for Õ stabilisere acetylcholinsammensetninger

Country Status (24)

Country Link
US (1) US6261546B1 (no)
EP (1) EP1073413B1 (no)
JP (1) JP2002512945A (no)
KR (1) KR100617429B1 (no)
CN (1) CN1147289C (no)
AT (1) ATE286380T1 (no)
AU (1) AU745124B2 (no)
BR (1) BR9910077A (no)
CA (1) CA2327398C (no)
CZ (1) CZ301969B6 (no)
DE (1) DE69923063T2 (no)
EE (1) EE04515B1 (no)
ES (1) ES2235486T3 (no)
HU (1) HU226104B1 (no)
ID (1) ID26032A (no)
IL (1) IL138775A0 (no)
NO (1) NO20005372D0 (no)
NZ (1) NZ507074A (no)
PL (1) PL194092B1 (no)
PT (1) PT1073413E (no)
RU (1) RU2225199C2 (no)
SI (1) SI1073413T1 (no)
UA (1) UA72209C2 (no)
WO (1) WO1999055304A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101595108A (zh) * 2006-11-30 2009-12-02 日本医事物理股份有限公司 对淀粉状蛋白具有亲和性的新化合物
US20130029919A1 (en) * 2011-07-26 2013-01-31 Allergan, Inc. Two part formulation system for opthalmic delivery

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009892A (en) * 1989-03-03 1991-04-23 Mckinzie James W Rapid miosis with control of intraocular pressure
RU2056821C1 (ru) * 1993-02-26 1996-03-27 Межотраслевой научно-технический комплекс "Микрохирургия глаза" Глазные капли "кератоник"
RU2100020C1 (ru) * 1993-06-23 1997-12-27 Лейрас Ой Средство для местного лечения глазной гипертензии и глаукомы и способ его получения
US5565188A (en) 1995-02-24 1996-10-15 Nanosystems L.L.C. Polyalkylene block copolymers as surface modifiers for nanoparticles
US5612027A (en) 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber

Also Published As

Publication number Publication date
CN1147289C (zh) 2004-04-28
JP2002512945A (ja) 2002-05-08
CA2327398C (en) 2008-12-30
PT1073413E (pt) 2005-04-29
US6261546B1 (en) 2001-07-17
NO20005372L (no) 2000-10-25
EP1073413B1 (en) 2005-01-05
HUP0100613A3 (en) 2001-12-28
KR100617429B1 (ko) 2006-08-30
CA2327398A1 (en) 1999-11-04
CN1298295A (zh) 2001-06-06
EP1073413A1 (en) 2001-02-07
DE69923063D1 (de) 2005-02-10
AU4034099A (en) 1999-11-16
WO1999055304A1 (en) 1999-11-04
CZ20003961A3 (cs) 2001-01-17
ATE286380T1 (de) 2005-01-15
AU745124B2 (en) 2002-03-14
ES2235486T3 (es) 2005-07-01
IL138775A0 (en) 2001-10-31
SI1073413T1 (no) 2005-08-31
ID26032A (id) 2000-11-16
RU2225199C2 (ru) 2004-03-10
NZ507074A (en) 2004-02-27
HUP0100613A2 (hu) 2001-08-28
EE04515B1 (et) 2005-08-15
HU226104B1 (en) 2008-04-28
BR9910077A (pt) 2000-12-26
PL343174A1 (en) 2001-07-30
DE69923063T2 (de) 2005-12-22
UA72209C2 (en) 2005-02-15
PL194092B1 (pl) 2007-04-30
CZ301969B6 (cs) 2010-08-18
HK1034204A1 (en) 2001-10-19
EE200000625A (et) 2002-02-15
KR20010043121A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
ATE173630T1 (de) Behandlung von entzündlichen darmerkrankungen mit interferon-gamma-inhibitoren
DE69617273D1 (de) Heterocyclisch substituierte cyclopentanderivate.
ATE177420T1 (de) Cyclobutan-derivate als inhibitoren der squalen- synthetase und der protein-farnesyltransferase
NO932620L (no) Amindiol-proteaseinhibitorer
DK0548114T5 (da) Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette
CA2200195A1 (en) Use of aromatase inhibitors for the production of a pharmaceutical agentfor treating a relative androgen deficiency in men
JO1696B1 (en) Acetamide derivatives
WO2002028829A3 (en) Peptide deformylase inhibitors
TW268937B (no)
WO2001087287A3 (en) Use of pyrazole derivatives for treating infertility
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
ES2111272T3 (es) Mezclas herbicidas.
ATE204851T1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
MXPA03001455A (es) Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa.
NO20005372D0 (no) FremgangsmÕter og sammensetninger for Õ stabilisere acetylcholinsammensetninger
DE69829963D1 (de) Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
AU2002313478A1 (en) Pharmaceutical preparation containing active ingredients extracted from the plants centella asiatica, mahonia aquifolium and viola tricolor
WO2004078180A3 (en) Naaladase inhibitors for treating opioid tolerance
RU94046300A (ru) Химические соединения, способ их получения, фармкомпозиция, способ лечения, промежуточный продукт
DE69626544D1 (de) Arzneistoffe
NO991419D0 (no) Farmas°ytiske sammensetninger omfattende S-alkylisotiouroniumderivater
WO2001016355A3 (de) In-vitro-testsystem für gamma-sekretase aus angereicherten-membranen
GEP20084346B (en) Protein kinase c inhibitors
EP1201764A3 (en) Assays for identifying phosphatase inhibitors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application